Jones Trading Downgrades OnKure Therapeutics Inc. (OKUR) to Hold May 6, 2026 08:15AM
OnKure Therapeutics (OKUR) Misses Q1 EPS by 111c May 5, 2026 05:54PM
OnKure Therapeutics (OKUR) files for 36.14M share offering by selling stockholders Apr 24, 2026 04:07PM
OnKure Therapeutics Inc. (OKUR) PT Lowered to $11 at Leerink Partners Mar 30, 2026 06:19AM
Oppenheimer on OnKure Therapeutics Inc. (OKUR): we like the pivot toward PI3Ka programs Mar 27, 2026 03:33PM


Mar 16, 2026 06:48AM OnKure Therapeutics Inc. (OKUR) PT Lowered to $27 at H.C. Wainwright
Nov 7, 2025 04:33PM OnKure Therapeutics (OKUR) Misses Q3 EPS by 109c
Aug 12, 2025 05:05PM OnKure Therapeutics (OKUR) Misses Q2 EPS by 114c
May 6, 2025 04:38PM OnKure Therapeutics (OKUR) Tops Q1 EPS by 119c
Apr 30, 2025 05:59AM Evercore ISI Starts OnKure Therapeutics Inc. (OKUR) at Outperform
Mar 18, 2025 06:39AM OnKure Therapeutics Inc. (OKUR) PT Lowered to $34 at H.C. Wainwright
Mar 10, 2025 04:46PM OnKure Therapeutics, Inc. (OKUR) Misses Q4 EPS by 130c
Jan 28, 2025 04:06PM Jones Trading Starts OnKure Therapeutics Inc. (OKUR) at Buy, PT $32
Dec 10, 2024 07:05AM OnKure (OKUR) Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219
Dec 5, 2024 06:20AM Leerink Partners Starts OnKure Therapeutics Inc. (OKUR) at Outperform
Oct 10, 2024 06:02AM Oppenheimer Starts OnKure Therapeutics Inc. (OKUR) at Outperform
Oct 4, 2024 04:59PM OnKure Therapeutics (OKUR) Completes Merger with Reneo Pharmaceuticals, Concurrent $65M Private Placement